Julie G. Allickson
Regenerative Medicine Clinical Center, Wake Forest Institute for Regenerative Medicine
Julie Allickson, Director of the Regenerative Medicine Clinical Center at Wake Forest Institute for Regenerative Medicine focuses on the translation of regenerative medicine products including cell therapy, tissue engineering, biomaterials and devices. This process begins at Proof-of-Concept where early discussion with regulators and clinicians are critical in moving the technology from the bench to the bedside. The Translational Team includes Quality Assurance, Quality Control, Regulatory Affairs, Process Development and the GMP-complaint Manufacturing Facility. Prior to joining the institute, she was an Executive Officer of the company and Vice President of Laboratory Operations and R & D at Cryo-Cell International, Inc. As Vice President of the Laboratory Dr. Allickson was responsible for all technical aspects of Laboratory Operations along with Research and Development activities associated with adult stem cells, and the commercialization of a unique stem cell harvested from menstrual blood. Prior to this position, Dr. Allickson worked for the University Of Miami School Of Medicine, Diabetes Research Institute as the Laboratory Director of the cGMP Hematopoietic Cell Processing Facility. She was responsible for the design and implementation of the State Licensed Clinical Flow Cytometry Laboratory. Dr. Allickson was the lead in Regulatory Affairs for the processing laboratory of Islet and Hematopoietic Cell products which included oversight of all Investigational New Drugs (IND) and external regulations. Prior to working for the University of Miami she worked for the American Red Cross managing the Hematopoietic Cell Processing and Platelet Serology Laboratory. During her tenure at the American Red Cross she served as a member of the National Stem Cell Task Force and participated in the preparation of national protocols developed for Hematopoietic Cell Processing Laboratories. Dr. Allickson was part of the team to perform the very first Bone Marrow Transplant at the University of Miami in 1990. Dr. Allickson has 25 years of experience in Cellular Therapy, Cellular Processing and Regenerative Medicine. She has a Doctorate in Health Sciences along with a Master’s Degree in Medical Laboratory Sciences. She is one of the founding members of the International Society of Cellular Therapy in 1992, has been a member of the American Association of Blood Banks (AABB) for 25 years along with other organizations such as TERMIS. She has presented at meetings related to cellular therapy, tissue engineering and biomaterial clinical translation. Dr. Allickson is on the AABB Standards Committee for Cell Therapy Product Services , Technical Advisory Board for Tissue Engineered Products under ICCBBA, Cord Blood Association on Market Expansion and Vice Chair of the Quality Committee and the ISCT Commercialization Committee.
Cellular Therapy, Cellular Processing and Regenerative Medicine,tissue engineering and biomaterial clinical translation.